Mostrar el registro sencillo del ítem

dc.contributor.authorVázquez-Román, V.
dc.contributor.authorCameselle Teijeiro, Jose Manuel 
dc.contributor.authorFernández-Santos, J.M.
dc.contributor.authorRíos-Moreno, M.J.
dc.contributor.authorLoidi Fernández de Trocóniz, Lourdes
dc.contributor.authorOrtiz, T.
dc.contributor.authorMartín-Lacave, I.
dc.date.accessioned2025-08-26T11:23:44Z
dc.date.available2025-08-26T11:23:44Z
dc.date.issued2022
dc.identifier.citationVázquez-Román, Cameselle-Teijeiro, Fernández-Santos, Ríos-Moreno, Loidi, Ortiz, et al. Histopathological Features of Pendred Syndrome Thyroids Align with Differences in the Expression of Thyroid-Specific Markers, Apical Iodide Transporters, and Ciliogenesis Process. Endocrine Pathology. 2022;33(4):484-93.
dc.identifier.issn1559-0097
dc.identifier.otherhttps://portalcientifico.sergas.gal/documentos/636708ee688cd71757e145c8*
dc.identifier.urihttp://hdl.handle.net/20.500.11940/20932
dc.description.abstractPendred syndrome (PDS) is an autosomal recessive disorder caused by mutations in the gene that encodes pendrin. Pendred thyroid tissue is supposedly altered by the absence of functional pendrin, but it is still unknown whether other iodide exchangers could compensate for the loss of the protein. Moreover, we have recently described that primary cilium, a conserved structure present at the apical surface of normal follicular cells, suffers different alterations in functional thyroid diseases. We aimed (1) to better understand the histopathological changes experienced by PDS thyroids, (2) to analyze the expression of different thyroid-specific genes and alternative iodide transporters and, finally, (3) to determine whether those changes may alter the morphological pattern of primary cilia in follicular cells. Thyroid samples from a series of four PDS patients were analyzed by immunohistochemistry, double immunofluorescence, and morphometry to evaluate changes in primary cilia frequency and length. We found thyroid follicular nodular disease in all PDS thyroids, frequently in association with follicular adenomas. There were only slight changes in the expression of thyroid-specific markers. Although no positivity for pendrin was found, cytoplasmic immunostaining for ANO-1, CLC-5, and CFTR was stronger in diffuse hyperplastic areas when compared to areas with highly cellular follicular nodules (HCFNs). HCFNs and follicular adenomas always showed diminished ciliary frequency and length. Our results suggest a direct relationship between the absence of functional pendrin and the loss of the normal thyroid architecture in PDS patients, which was also accompanied by differences in the expression of specific immunohistochemical markers and altered ciliogenesis. The present data may help the pathologist in screening for PDS.en
dc.description.sponsorshipOpen Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This work was supported by grants from (JMF) the Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (ref. CTS-439/2017), (JMC-T) by Grant ISCIII-PI19/01316-FEDER from Instituto de Salud Carlos III, State Research Agency (AEI), and Ministry of Science and Innovation, Spain.en
dc.language.isoeng
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleHistopathological Features of Pendred Syndrome Thyroids Align with Differences in the Expression of Thyroid-Specific Markers, Apical Iodide Transporters, and Ciliogenesis Process*
dc.typeArticleen
dc.authorsophosVázquez-Román, I. V.
dc.authorsophosCameselle-Teijeiro, J. M.
dc.authorsophosFernández-Santos, J. M.
dc.authorsophosRíos-Moreno, M. J.
dc.authorsophosLoidi, L.
dc.authorsophosOrtiz, T.
dc.authorsophosMartín, Lacave
dc.identifier.doi10.1007/s12022-022-09732-2
dc.identifier.sophos636708ee688cd71757e145c8
dc.issue.number4
dc.journal.titleEndocrine Pathology*
dc.page.initial484
dc.page.final493
dc.relation.projectIDCRUE-CSIC agreement; Springer Nature; Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia [CTS-439/2017]; Instituto de Salud Carlos III, State Research Agency (AEI) [ISCIII-PI19/01316-FEDER]; Ministry of Science and Innovation, Spain
dc.relation.publisherversionhttps://link.springer.com/content/pdf/10.1007%2Fs12022-022-09732-2.pdf;https://link.springer.com/content/pdf/10.1007/s12022-022-09732-2.pdfes
dc.rights.accessRightsopenAccess
dc.subject.keywordIDISes
dc.subject.keywordAS Santiagoes
dc.subject.keywordCHUSes
dc.subject.keywordFPGMXes
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)es
dc.typesophosArtículo Originales
dc.volume.number33


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional